1. Home
  2. BSX vs COR Comparison

BSX vs COR Comparison

Compare BSX & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$46.84

Market Cap

65.8B

Sector

Health Care

ML Signal

HOLD

Logo Cencora Inc.

COR

Cencora Inc.

HOLD

Current Price

$321.94

Market Cap

59.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSX
COR
Founded
1979
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Other Pharmaceuticals
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.8B
59.9B
IPO Year
2010
2001

Fundamental Metrics

Financial Performance
Metric
BSX
COR
Price
$46.84
$321.94
Analyst Decision
Strong Buy
Buy
Analyst Count
22
14
Target Price
$93.18
$390.62
AVG Volume (30 Days)
18.5M
1.3M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
N/A
0.77%
EPS Growth
55.20
5.71
EPS
1.51
15.21
Revenue
$9,076,000,000.00
$321,332,819,000.00
Revenue This Year
$11.85
$8.89
Revenue Next Year
$10.16
$6.75
P/E Ratio
$30.88
$21.12
Revenue Growth
12.49
9.31
52 Week Low
$42.20
$244.82
52 Week High
$109.50
$377.54

Technical Indicators

Market Signals
Indicator
BSX
COR
Relative Strength Index (RSI) 44.32 55.61
Support Level $42.32 $299.49
Resistance Level $50.14 $329.28
Average True Range (ATR) 1.53 7.15
MACD -0.57 -0.19
Stochastic Oscillator 8.31 62.58

Price Performance

Historical Comparison
BSX
COR

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

About COR Cencora Inc.

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Share on Social Networks: